Browse 881 autoimmune disorders clinical trials enrolling across the United States and Canada. 117 people applied to autoimmune disorders studies last month. Search by city or state to find one near you.
There are more than 80 autoimmune diseases, from rheumatoid arthritis and psoriasis to lupus and multiple sclerosis, and together they affect a large share of people, most of them women. In each one, the immune system mistakenly attacks the body's own tissues. Treatment has moved from broad immune suppression to medicines that block specific immune signals, and most recently to approaches that aim to reset the immune system entirely.
Location: New Hyde Park NY, Neptune City NJ, Hackensack NJ,
Sponsor: Travere Therapeutics, Inc.
Sex: All
Age: 1 - 17
Code: NCT05003986
Phase 2, Recruiting
Immunoregulatory Effect of Microparticle Delivered STING Agonist in the Control of Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)
for
Relapse Remitting Multiple Sclerosis
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: All
Age: 18 - 55
Code: NCT05705986
Recruiting
Impact of Capillaroscopy on the Management of Undifferentiated Connective Tissue Disease
for
Undifferentiated Connective Tissue Diseases
Location: Quebec
Sponsor: CHU de Quebec-Universite Laval
Sex: All
Age: 18+
Code: NCT06399822
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: Female
Age: 18+
Code: NCT00188357
Recruiting
Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients
for
Autoimmune Lymphoproliferative Syndrome
Location: Philadelphia PA, Bethesda MD, Houston TX
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 16 - 70+
Code: NCT06730126
Phase 2, Recruiting
Transdisciplinary Care for Young Adults With Type 1 Diabetes
for
Type 1 Diabetes
Location: Wilmington DE, Orlando FL
Sponsor: Nemours Children's Clinic
Sex: All
Age: 17+
Code: NCT06172166
Recruiting
Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS
for
Multiple Sclerosis
Location: Boulder CO
Sponsor: University of Colorado, Boulder
Sex: All
Age: 18 - 65
Code: NCT05500963
Recruiting
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
for
Relapsing Multiple Sclerosis
Location: Boston MA, Foxborough MA, Wellesley MA,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT05877963
Phase 3, Recruiting
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis
Location: Ottawa
Sponsor: argenx
Sex: All
Age: 2 - 17
Code: NCT06392386
Phase 2, Phase 3, Recruiting
Improving Diabetes Equity and Advancing Care Study
for
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 1,
Location: Chicago IL
Sponsor: Sinai Health System
Sex: All
Age: 18+
Code: NCT06040463
Recruiting
Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features
for
Diabetes Mellitus, Diabetes Mellitus, Type 1,
Location: San Antonio TX, Idaho Falls ID, Renton WA, Escondido CA